Live Breaking News & Updates on Advanced Prostate Cancer

Stay updated with breaking news from Advanced prostate cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Prostate Cancer: Treatment Options - Surgery, Radiation Therapy, Hormone Therapy

Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemotherapy, cryosurgery or biologic therapy. ....

United States , Trupti Shirole , Prostate Cancer , Prostate Specific Antigen , Treatment Options , Radiation Therapy , Localized Prostate , Advanced Prostate Cancer , Advanced Prostate Cancer Consensus Conference , Hormone Sensitive Prostate Cancer , Current Treatment , Prostate Cancer Treatment , Prostate Gland , Female Reproductive System , Ancer Of The Prostate Gland , Rognosis For Prostate Cancer ,

Medical Management of Prostate Cancer

Prostate cancer is the second most common cancer in men after skin cancer and it is the sixth leading cause of death in men worldwide. ....

United States , Puerto Rico , Puerto Rican , Gautam Chopra , Vaibhav Vishal , Arun Narayanaswamy , Sneha Bhatt , Arun Kumar Balakrishnan , National Association Of Proton Therapy , American Society Of Clinical Oncology , American Cancer Society , European Association Of Urology , Medical Management , Stage Prostate , European Association , Treatment Drug Options , Clinical Oncology , Prostate Cancer , Physical Activity , Prostate Cancer Mortality , Puerto Rican Men , National Association , Proton Therapy , Advanced Prostate Cancer , Advanced Prostate Cancer Consensus Conference ,

Farber disease-Causes-Symptoms-Diagnosis-Treatment-Prognosis-Prevention-FAQs

Farber disease is a genetic disease characterised by the deficiency of ceramidase. It has no specific treatment. ....

United States , Johannes Roth , Axel Zander , Michael Frosch , Nithin Jayan , Karoline Ehlert , Natalja Fehse , From Booth Hall Children , Rheumatic Diseases , Josef Vormoor Pediatric Rheumatology , Response Assessment , Advanced Prostate Cancer , Advanced Prostate Cancer Consensus Conference ,

Apalutamide Dose Reduction Does Not Significantly Reduce Skin-related AEs in Advanced Prostate Cancer

Reduced doses of apalutamide did not significantly decrease rates of skin-related adverse effects vs full-dose apalutamide in patients with advanced prostate cancer. ....

United States , Kyo Togashi , Hirosaki University Graduate School Of Medicine , Department Of Urology , Administration Of Apalutamide , American Urological Association Annual Meeting , Urological Association Annual , Hirosaki University Graduate School , Advanced Prostate Cancer , Aua Annual Meeting , 2023 American Urological Association Annual Meeting ,

Johnson & Johnson : Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorization for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

BEERSE, Belgium, 21 April 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission has granted marketing authorisation for AKEEGA®. | April 21, 2023 ....

Region Flamande , United Kingdom , City Of , Janssen Cilag Gmb , Martin Vogel , Magda Palhota , Peter Lebowitz , Gerhardt Attard , Janssen Cilag Gm , Urology Care Foundation , Exchange Commission , Drug Administration , Companies Of Johnson , Janssen Research Development , European Medicines Agency , University College London , None Of The Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies , Tesaro Inc , European Commission , Janssen Pharmaceutical Companies Of Johnson , Drug Administration Seeking Approval Of Niraparib , European Union , Janssen Cilag International , Janssen Biotech Inc , Professor Gerhardt Attard ,